Sclerotherapy with 3% polidocanol foam in the treatment of hemorrhoidal disease: unveiling the missing pieces for a comprehensive evaluation

Front Surg. 2023 Dec 21:10:1344724. doi: 10.3389/fsurg.2023.1344724. eCollection 2023.
No abstract available

Keywords: 3% polidocanol foam; hemorrhoidal disease; hemorrhoids; office-based procedure; sclerotherapy.

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.